We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Imperva, Inc. | NASDAQ:IMPV | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 55.74 | 45.00 | 199,999.99 | 0 | 00:00:00 |
MILWAUKEE, Oct. 10, 2018 /PRNewswire/ -- Ademi & O'Reilly, LLP is investigating the Board of Imperva Technologies Corporation (Nasdaq:IMPV) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Imperva to Thoma Bravo.
Click here to learn how to join the action: http://ademilaw.com/case/imperva or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Ademi & O'Reilly, LLP alleges Imperva's long-term financial outlook is improving and yet Imperva shareholders will receive the equivalent of only $55.75 for each share of Imperva common stock. Thoma Bravo is well aware of Imperva's improving financial metrics and is purchasing Imperva at a substantial discount. The merger agreement unreasonably limits competing bids for Imperva by (i) prohibiting solicitation of any further bids, and (ii) imposing a termination penalty should Imperva receive and accept a superior bid. Imperva insiders, their affiliates and other major shareholders own significant voting stock, and will receive millions of dollars as part of change of control arrangements, and therefore can unduly influence a sale of Imperva. Our investigation centers on the conduct of Imperva's Board of Directors, who have unanimously approved the transaction, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Imperva given its current financial condition and prospects.
If you own common stock in Imperva and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or http://ademilaw.com/case/imperva.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi & O'Reilly, LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
View original content:http://www.prnewswire.com/news-releases/shareholder-alert-ademi--oreilly-llp-investigates-whether-imperva-inc-has-obtained-a-fair-price-in-its-sale-to-thoma-bravo-llc-300728764.html
SOURCE Ademi & O'Reilly, LLP
Copyright 2018 PR Newswire
1 Year Imperva, Inc. Chart |
1 Month Imperva, Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions